Tetrandrine induces cell death in SAS human oral cancer cells through caspase activation-dependent apoptosis and LC3-I and LC3-II activation-dependent autophagy

International Journal of Oncology

Volumn 43, Issue 2, 2013, Pages 485-494

  Huang, An Cheng ^a   Lien, Jin Cherng ^b   Lin, Meng Wei ^c   Yang, Jai Sing ^b   Wu, Ping Ping ^b   Chang, Shu Jen ^b   Lai, Tung Yuan ^d,e  

^a St Mary's College   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c CARDINAL TIEN COLLEGE OF HEALTHCARE AND MANAGEMENT   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Apoptosis; Autophagy; Human oral cancer SAS cells; LC3; Tetrandrine

Indexed keywords

AUTOPHAGY PROTEIN 5; BAFILOMYCIN A1; BECLIN 1; CADAVERINE; CASPASE 3; CASPASE 8; CASPASE 9; LIPOCORTIN 5; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN KINASE B; SMALL INTERFERING RNA; TETRANDRINE;

APOPTOSIS; ARTICLE; AUTOPHAGY; CELL DEATH; CELL STRUCTURE; CELL VIABILITY; HUMAN; HUMAN CELL; LIGHT CHAIN; LIGHT CHAIN 3; MOUTH CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTIRHEUMATIC AGENTS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; AUTOPHAGY; BENZYLISOQUINOLINES; CARCINOMA, SQUAMOUS CELL; CASPASE 3; CELL LINE, TUMOR; CELL SURVIVAL; CHLOROQUINE; ENZYME INHIBITORS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MACROLIDES; MEMBRANE PROTEINS; MICROTUBULE-ASSOCIATED PROTEINS; MOUTH NEOPLASMS; POLY(ADP-RIBOSE) POLYMERASES; PROTEIN-SERINE-THREONINE KINASES; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 84879639056     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2013.1952     Document Type: Article

References (62)

1. Tseng CH: Oral cancer in Taiwan: is diabetes a risk factor? Clin Oral Investig: Aug 16, 2012 (Epub ahead of print).
2. Bau DT, Tseng HC, Wang CH, et al: Oral cancer and genetic polymorphism of DNA double strand break gene Ku70 in Taiwan. Oral Oncol 44: 1047-1051, 2008.
3. Chie WC, Li CY, Huang CS, Chang KJ, Yen ML and Lin RS: Oral contraceptives and breast cancer risk in Taiwan, a country of low incidence of breast cancer and low use of oral contraceptives. Int J Cancer 77: 219-223, 1998.
4. Zavras AI, Douglass CW, Joshipura K, et al: Smoking and alcohol in the etiology of oral cancer: gender-specific risk profiles in the south of Greece. Oral Oncol 37: 28-35, 2001.
5. Moreno-Lopez LA, Esparza-Gomez GC, Gonzalez-Navarro A, Cerero-Lapiedra R, Gonzalez-Hernandez MJ and Dominguez- Rojas V: Risk of oral cancer associated with tobacco smoking, alcohol consumption and oral hygiene: a case-control study in Madrid, Spain. Oral Oncol 36: 170-174, 2000.
6. Kerawala CJ: Oral cancer, smoking and alcohol: the patients' perspective. Br J Oral Maxillofac Surg 37: 374-376, 1999.
7. Shukla D, Dinesh Kale A, Hallikerimath S, Vivekanandhan S and Venkatakanthaiah Y: Genetic polymorphism of drug metabolizing enzymes (GSTM1 and CYP1A1) as risk factors for oral premalignant lesions and oral cancer. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 156: 253-259, 2012.
8. Plu-Bureau G, Bossard N and Thalabard JC: Oral contraception and genetic factors in breast cancer: characteristics and limits of case-only studies. Rev Epidemiol Sante Publique 48: 294-303, 2000 (In French). (Pubitemid 30490268)
9. Hung HC, Chuang J, Chien YC, et al: Genetic polymorphisms of CYP2E1, GSTM1, and GSTT1; environmental factors and risk of oral cancer. Cancer Epidemiol Biomarkers Prev 6: 901-905, 1997. (Pubitemid 27481638)
10. Yang YY, Koh LW, Tsai JH, et al: Involvement of viral and chemical factors with oral cancer in Taiwan. Jpn J Clin Oncol 34: 176-183, 2004.
11. Jung J, Cho NH, Kim J, et al: Significant invasion depth of early oral tongue cancer originated from the lateral border to predict regional metastases and prognosis. Int J Oral Maxillofac Surg 38: 653-660, 2009.
12. Hour MJ, Lee KT, Wu YC, et al: A novel antitubulin agent, DPQZ, induces cell apoptosis in human oral cancer cells through Ras/Raf inhibition and MAP kinases activation. Arch Toxicol: Dec 5, 2012 (Epub ahead of print).
13. Shin JA, Kim JS, Hong IS and Cho SD: Bak is a key molecule in apoptosis induced by methanol extracts of Codonopsis lanceolata and Tricholoma matsutake in HSC-2 human oral cancer cells. Oncol Lett 4: 1379-1383, 2012.
14. Tsai SC, Lu CC, Lee CY, et al: AKT serine/threonine protein kinase modulates bufalin-triggered intrinsic pathway of apoptosis in CAL 27 human oral cancer cells. Int J Oncol 41: 1683-1692, 2012.
15. Xu XH, Gan YC, Xu GB, et al: Tetrandrine citrate eliminates imatinib-resistant chronic myeloid leukemia cells in vitro and in vivo by inhibiting Bcr-Abl/β-catenin axis. J Zhejiang Univ Sci B 13: 867-874, 2012.
16. Gao S, Cui YL, Yu CQ, Wang QS and Zhang Y: Tetrandrine exerts antidepressant-like effects in animal models: role of brain-derived neurotrophic factor. Behav Brain Res 238: 79-85, 2013.
17. Gong K, Chen C, Zhan Y, Chen Y, Huang Z and Li W: Autophagy-related gene 7 (ATG7) and reactive oxygen species/extracellular signal-regulated kinase regulate tetrandrine- induced autophagy in human hepatocellular carcinoma. J Biol Chem 287: 35576-35588, 2012.
18. Shan QQ, Gong YP, Guo Y, Lin J, Zhou RQ and Yang X: Anti-tumor effect of tanshinone II A, tetrandrine, honokiol, curcumin, oridonin and paeonol on leukemia cell lines. Sichuan Da Xue Xue Bao Yi Xue Ban 43: 362-366, 2012 (In Chinese).
19. Wang G, Lemos JR and Iadecola C: Herbal alkaloid tetrandrine: fron an ion channel blocker to inhibitor of tumor proliferation. Trends Pharmacol Sci 25: 120-123, 2004. (Pubitemid 38264500)
20. Rao MR: Effects of tetrandrine on cardiac and vascular remodeling. Acta Pharmacol Sin 23: 1075-1085, 2002.
21. Li X, Lu X, Xu H, et al: Paclitaxel/tetrandrine coloaded nanoparticles effectively promote the apoptosis of gastric cancer cells based on 'oxidation therapy'. Mol Pharm 9: 222-229, 2012.
22. Wu JM, Chen Y, Chen JC, Lin TY and Tseng SH: Tetrandrine induces apoptosis and growth suppression of colon cancer cells in mice. Cancer Lett 287: 187-195, 2010.
23. Liu B, Wang T, Qian X, Liu G, Yu L and Ding Y: Anticancer effect of tetrandrine on primary cancer cells isolated from ascites and pleural fluids. Cancer Lett 268: 166-175, 2008.
24. Chen YJ: Potential role of tetrandrine in cancer therapy. Acta Pharmacol Sin 23: 1102-1106, 2002.
25. Ye Z, Sun A, Li L, Cao X and Ye W: Reversal of adriamycin or vincristine resistance by tetrandrine in human cancer cells in vitro. Zhongguo Zhong Yao Za Zhi 21: 369-371, 384, 1996 (In Chinese).
26. Jin Q, Kang C, Soh Y, et al: Tetrandrine cytotoxicity and its dual effect on oxidative stress-induced apoptosis through modulating cellular redox states in Neuro 2a mouse neuroblastoma cells. Life Sci 71: 2053-2066, 2002.
27. Kuo PL and Lin CC: Tetrandrine-induced cell cycle arrest and apoptosis in Hep G2 cells. Life Sci 73: 243-252, 2003.
28. Cheng F, Li Y, Feng L and Li S: Effects of tetrandrine on ischemia/reperfusion injury in mouse liver. Transplant Proc 40: 2163-2166, 2008.
29. Zhang P, Tang Iu N and Zhao YC: The effects of Tetrandrine on the changes of IL-1beta, TNF-alpha and IL-8 after cerebral ischemia/reperfusion in rats. Zhongguo Ying Yong Sheng Li Xue Za Zhi 22: 443-444, 478, 2006 (In Chinese).
30. Liu Z, Xu Z, Shen W, Li Y, Zhang J and Ye X: Effect of pharmacologic preconditioning with tetrandrine on subsequent ischemia/ reperfusion injury in rat liver. World J Surg 28: 620-624, 2004. (Pubitemid 38802802)
31. Chen Y, Chen JC and Tseng SH: Tetrandrine suppresses tumor growth and angiogenesis of gliomas in rats. Int J Cancer 124: 2260-2269, 2009.
32. Qian XP, Liu BR, Hu J, et al: Inhibitory effect of tetrandrine on angiogenesis. Ai Zheng 27: 1050-1055, 2008 (In Chinese).
33. Kobayashi S, Kimura I, Fukuta M, et al: Inhibitory effects of tetrandrine and related synthetic compounds on angiogenesis in streptozotocin-diabetic rodents. Biol Pharm Bull 22: 360-365, 1999. (Pubitemid 29219977)
34. Kobayashi S, Inaba K, Kimura I and Kimura M: Inhibitory effects of tetrandrine on angiogenesis in adjuvant-induced chronic inflammation and tube formation of vascular endothelial cells. Biol Pharm Bull 21: 346-349, 1998. (Pubitemid 28216970)
35. Liu C, Gong K, Mao X and Li W: Tetrandrine induces apoptosis by activating reactive oxygen species and repressing Akt activity in human hepatocellular carcinoma. Int J Cancer 129: 1519-1531, 2011.
36. Chen XL, Ren KH, He HW and Shao RG: Involvement of PI3K/ AKT/GSK3beta pathway in tetrandrine-induced G1 arrest and apoptosis. Cancer Biol Ther 7: 1073-1078, 2008.
37. Li X, Su B, Liu R, Wu D and He D: Tetrandrine induces apoptosis and triggers caspase cascade in human bladder cancer cells. J Surg Res 166: e45-e51, 2011.
38. Lu KW, Chen JC, Lai TY, et al: Gypenosides suppress growth of human oral cancer SAS cells in vitro and in a murine xenograft model: the role of apoptosis mediated by caspase-dependent and caspase-independent pathways. Integr Cancer Ther 11: 129-140, 2012.
39. Lu KW, Chen JC, Lai TY, et al: Gypenosides causes DNA damage and inhibits expression of DNA repair genes of human oral cancer SAS cells. In Vivo 24: 287-291, 2010.
40. Lu KW, Chen JC, Lai TY, et al: Gypenosides inhibits migration and invasion of human oral cancer SAS cells through the inhibition of matrix metalloproteinase-2 -9 and urokinase-plasminogen by ERK1/2 and NF-kappa B signaling pathways. Hum Exp Toxicol 30: 406-415, 2011.
41. Xie CM, Chan WY, Yu S, Zhao J and Cheng CH: Bufalin induces autophagy-mediated cell death in human colon cancer cells through reactive oxygen species generation and JNK activation. Free Radic Biol Med 51: 1365-1375, 2011.
42. Vazquez CL and Colombo MI: Assays to assess autophagy induction and fusion of autophagic vacuoles with a degradative compartment, using monodansylcadaverine (MDC) and DQ-BSA. Methods Enzymol 452: 85-95, 2009.
43. Chueh FS, Chen YL, Hsu SC, et al: Triptolide induced DNA damage in A375.S2 human malignant melanoma cells is mediated via reduction of DNA repair genes. Oncol Rep 29: 613-618, 2013.
44. Revonta M, Raitanen J, Sihvo S, et al: Health and life style among infertile men and women. Sex Reprod Healthc 1: 91-98, 2010.
45. Palefsky JM, Gillison ML and Strickler HD: Chapter 16: HPV vaccines in immunocompromised women and men. Vaccine 24 (Suppl 3): S3/140-146, 2006.
46. Gondi CS and Rao JS: Cathepsin B as a cancer target. Expert Opin Ther Targets 17: 281-291, 2013.
47. Tekpli X, Holme JA, Sergent O and Lagadic-Gossmann D: Role for membrane remodeling in cell death: Implication for health and disease. Toxicology 304: 141-157, 2013.
48. Zhang XY, Xi XY and Zhao ZD: Autophagy inhibitor 3-MA decreases the production and release of infectious enterovirus 71 particles. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 25: 176-178, 2011 (In Chinese).
49. Liu D, Yang Y, Liu Q and Wang J: Inhibition of autophagy by 3-MA potentiates cisplatin-induced apoptosis in esophageal squamous cell carcinoma cells. Med Oncol 28: 105-111, 2011.
50. He Y, Zhao X, Gao J, et al: Quantum dots-based immunofluorescent imaging of stromal fibroblasts caveolin-1 and light chain 3b expression and identification of their clinical significance in human gastric cancer. Int J Mol Sci 13: 13764-13780, 2012.
51. Liu GH, Zhong Q, Ye YL, et al: Expression of beclin 1 in bladder cancer and its clinical significance. Int J Biol Markers: Nov 5, 2012 (Epub ahead of print).
52. Levy JM and Thorburn A: Targeting autophagy during cancer therapy to improve clinical outcomes. Pharmacol Ther 131: 130-141, 2011.
53. Schrump DS: Cytotoxicity mediated by histone deacetylase inhibitors in cancer cells: mechanisms and potential clinical implications. Clin Cancer Res 15: 3947-3957, 2009.
54. Shen Y, Liang LZ, Hong MH, Xiong Y, Wei M and Zhu XF: Expression and clinical significance of microtubule-associated protein 1 light chain 3 (LC3) and Beclin1 in epithelial ovarian cancer. Ai Zheng 27: 595-599, 2008 (In Chinese).
55. Pavlides S, Vera I, Gandara R, et al: Warburg meets autophagy: cancer-associated fibroblasts accelerate tumor growth and metastasis via oxidative stress, mitophagy, and aerobic glycolysis. Antioxid Redox Signal 16: 1264-1284, 2012.
56. McLeland CB, Rodriguez J and Stern ST: Autophagy monitoring assay: qualitative analysis of MAP LC3-I to II conversion by immunoblot. Methods Mol Biol 697: 199-206, 2011.
57. Reggiori F, Monastyrska I, Verheije MH, et al: Coronaviruses Hijack the LC3-I-positive EDEMosomes, ER-derived vesicles exporting short-lived ERAD regulators, for replication. Cell Host Microbe 7: 500-508, 2010.
58. Gimenez-Xavier P, Francisco R, Platini F, Perez R and Ambrosio S: LC3-I conversion to LC3-II does not necessarily result in complete autophagy. Int J Mol Med 22: 781-785, 2008.
59. Cao Y, Nair U, Yasumura-Yorimitsu K and Klionsky DJ: A multiple ATG gene knockout strain for yeast two-hybrid analysis. Autophagy 5: 699-705, 2009.
60. Noda NN, Ohsumi Y and Inagaki F: ATG systems from the protein structural point of view. Chem Rev 109: 1587-1598, 2009.
61. Stasyk OV, Nazarko TY and Sibirny AA: Methods of plate pexophagy monitoring and positive selection for ATG gene cloning in yeasts. Methods Enzymol 451: 229-239, 2008.
62. Chung T, Suttangkakul A and Vierstra RD: The ATG autophagic conjugation system in maize: ATG transcripts and abundance of the ATG8-lipid adduct are regulated by development and nutrient availability. Plant Physiol 149: 220-234, 2009.